Catapult Pharmacology
Class 1A Antiarrhythmics
Class 1A Antiarrhythmic drugs prolong the refractory period and slow conduction of electrical impulses. Class 1A drugs work by blocking fast sodium channels, which prolongs phase 0 depolarization. Prolonging phase 0 reduces conduction velocity and increases the refractory period. These effects decrease myocardial excitability. These medications are not widely used; however, procainamide can be used in the treatment of atrial fibrillation/flutter in the setting of Wolff-Parkinson-White syndrome.
Class Drugs
Quinidine
Procainamide
Disopyramide
Class Mechanism of Action
Blocks voltage sensitive sodium channels
- Slows phase 0 in ventricle
Potassium channel inhibition
- Slows phase 3 and increases effective refractory period
Calcium channel blocker
Anticholinergic

Class IA Antiarrhythmics diagram
Class Applications
Treatment of tachy-arrhythmias
Atrial
AV junctional
Ventricular
Class Adverse Effects
- Anticholinergic effects (dry mouth, urinary retention, etc.)
Drug Table
| Drug Name | Application | Comments | Image |
|---|---|---|---|
| Quinidine | Maintenance of sinus rhythm after conversion from atrial fibrillation/flutter; Suppression of ventricular tachycardia and ventricular ectopic beats; Malaria | Mechanism; In addition; Alpha blocking effects; Adverse Effects; Cinchonism - tinnitus, blurred vision, diarrhea; Prolonged QT, ventricular arrhythmias; Thrombocytopenia; Skeletal muscle weakness; Hypotension; Drug Interactions: digoxin, warfarin | "Quill" "Dining Table" |
| Procainamide | Atrial fibrillation or flutter in setting of Wolff-Parkinson-White syndrome | Pharmacokinetics; Active metabolite present:; -NAPA (N-acetylprocainamide) is produced in the liver and acts as a Class III antiarrhythmic drug; Adverse Effects; May cause hypotension; Lupus-like syndrome | "Professional" "Cain" |
| Disopyramide | Rarely used. May be used in maintenance of sinus rhythm in atrial fibrillation or atrial flutter.; Also used as an alternative to procainamide or quinidine | Adverse Effects; Negative inotropic effect, which may cause dysfunction in patients with systolic heart failure | "Dice" "Pyramid" |